Previous studies have demonstrated that medications commonly utilized for managing MetS or diabetes, including intranasal insulin, metformin, incretin-based therapies, and thiazolidinediones, can also ameliorate some dementia symptoms (Ishmuratova et al., 2023). The gene discussed is INS; the disease is metabolic syndrome.